Suppr超能文献

通过网络药理学方法鉴定荷叶碱的抗肿瘤活性及作用机制。

Identification of the anti-tumor activity and mechanisms of nuciferine through a network pharmacology approach.

作者信息

Qi Quan, Li Rui, Li Hui-Ying, Cao Yu-Bing, Bai Ming, Fan Xiao-Jing, Wang Shu-Yan, Zhang Bo, Li Shao

机构信息

Tianjin State Key Laboratory of Modern Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China.

MOE Key Lab of Bioinformatics, Bioinformatics Division, TNLIST and Department of Automation, Tsinghua University, Beijing 100084, China.

出版信息

Acta Pharmacol Sin. 2016 Jul;37(7):963-72. doi: 10.1038/aps.2016.53. Epub 2016 May 16.

Abstract

AIM

Nuciferine is an aporphine alkaloid extracted from lotus leaves, which is a raw material in Chinese medicinal herb for weight loss. In this study we used a network pharmacology approach to identify the anti-tumor activity of nuciferine and the underlying mechanisms.

METHODS

The pharmacological activities and mechanisms of nuciferine were identified through target profile prediction, clustering analysis and functional enrichment analysis using our traditional Chinese medicine (TCM) network pharmacology platform. The anti-tumor activity of nuciferine was validated by in vitro and in vivo experiments. The anti-tumor mechanisms of nuciferine were predicted through network target analysis and verified by in vitro experiments.

RESULTS

The nuciferine target profile was enriched with signaling pathways and biological functions, including "regulation of lipase activity", "response to nicotine" and "regulation of cell proliferation". Target profile clustering results suggested that nuciferine to exert anti-tumor effect. In experimental validation, nuciferine (0.8 mg/mL) markedly inhibited the viability of human neuroblastoma SY5Y cells and mouse colorectal cancer CT26 cells in vitro, and nuciferine (0.05 mg/mL) significantly suppressed the invasion of 6 cancer cell lines in vitro. Intraperitoneal injection of nuciferine (9.5 mg/mL, ip, 3 times a week for 3 weeks) significantly decreased the weight of SY5Y and CT26 tumor xenografts in nude mice. Network target analysis and experimental validation in SY5Y and CT26 cells showed that the anti-tumor effect of nuciferine was mediated through inhibiting the PI3K-AKT signaling pathway and IL-1 levels in SY5Y and CT26 cells.

CONCLUSION

By using a TCM network pharmacology method, nuciferine is identified as an anti-tumor agent against human neuroblastoma and mouse colorectal cancer in vitro and in vivo, through inhibiting the PI3K-AKT signaling pathways and IL-1 levels.

摘要

目的

荷叶碱是从荷叶中提取的一种阿朴啡生物碱,是一种用于减肥的中草药原料。在本研究中,我们采用网络药理学方法来确定荷叶碱的抗肿瘤活性及其潜在机制。

方法

通过使用我们的中药网络药理学平台进行靶点预测、聚类分析和功能富集分析,来确定荷叶碱的药理活性和机制。通过体外和体内实验验证荷叶碱的抗肿瘤活性。通过网络靶点分析预测荷叶碱的抗肿瘤机制,并通过体外实验进行验证。

结果

荷叶碱的靶点谱富含信号通路和生物学功能,包括“脂肪酶活性调节”、“对尼古丁的反应”和“细胞增殖调节”。靶点谱聚类结果表明荷叶碱具有抗肿瘤作用。在实验验证中,荷叶碱(0.8 mg/mL)在体外显著抑制人神经母细胞瘤SY5Y细胞和小鼠结直肠癌CT26细胞的活力,荷叶碱(0.05 mg/mL)在体外显著抑制6种癌细胞系的侵袭。腹腔注射荷叶碱(9.5 mg/mL,腹腔注射,每周3次,共3周)显著降低裸鼠体内SY5Y和CT26肿瘤异种移植瘤的重量。在SY5Y和CT26细胞中的网络靶点分析和实验验证表明,荷叶碱的抗肿瘤作用是通过抑制SY5Y和CT26细胞中的PI3K-AKT信号通路和IL-1水平来介导的。

结论

通过使用中药网络药理学方法,确定荷叶碱在体外和体内均为针对人神经母细胞瘤和小鼠结直肠癌的抗肿瘤药物,其作用机制是抑制PI3K-AKT信号通路和IL-1水平。

相似文献

1
Identification of the anti-tumor activity and mechanisms of nuciferine through a network pharmacology approach.
Acta Pharmacol Sin. 2016 Jul;37(7):963-72. doi: 10.1038/aps.2016.53. Epub 2016 May 16.
4
Nuciferine restores potassium oxonate-induced hyperuricemia and kidney inflammation in mice.
Eur J Pharmacol. 2015 Jan 15;747:59-70. doi: 10.1016/j.ejphar.2014.11.035. Epub 2014 Dec 8.
6
Advances in the pharmacological effects and mechanisms of Nelumbo nucifera gaertn. Extract nuciferine.
J Ethnopharmacol. 2024 Sep 15;331:118262. doi: 10.1016/j.jep.2024.118262. Epub 2024 Apr 24.
9
Nuciferine Relaxes Tracheal Rings via the Blockade of VDLCC and NSCC Channels.
Planta Med. 2018 Jan;84(2):83-90. doi: 10.1055/s-0043-118178. Epub 2017 Aug 17.
10
Nuciferine Inhibits Skin Cutaneous Melanoma Cell Growth by Suppressing TLR4/NF-κB Signaling.
Anticancer Agents Med Chem. 2020;20(17):2099-2105. doi: 10.2174/1871520620666200811114607.

引用本文的文献

2
Cancer network pharmacology: multi-network regulatory mechanisms and future directions.
Med Oncol. 2025 Jun 12;42(7):255. doi: 10.1007/s12032-025-02811-4.
3
Comprehensive dataset of heterogeneous network structures in traditional chinese medicine research.
Data Brief. 2024 Sep 26;57:110962. doi: 10.1016/j.dib.2024.110962. eCollection 2024 Dec.
6
Skin-Whitening Effect of a Callus Extract of Isolate Haman.
Plants (Basel). 2023 Nov 21;12(23):3923. doi: 10.3390/plants12233923.

本文引用的文献

1
Tetramethylpyrazine identified by a network pharmacology approach ameliorates methotrexate-induced oxidative organ injury.
J Ethnopharmacol. 2015 Dec 4;175:638-47. doi: 10.1016/j.jep.2015.09.034. Epub 2015 Oct 3.
3
Network pharmacology: a new approach to unveiling Traditional Chinese Medicine.
Chin J Nat Med. 2015 Jan;13(1):1-2. doi: 10.1016/S1875-5364(15)60001-2.
4
Antioxidant and anticancer aporphine alkaloids from the leaves of Nelumbo nucifera Gaertn. cv. Rosa-plena.
Molecules. 2014 Nov 3;19(11):17829-38. doi: 10.3390/molecules191117829.
6
Traditional Chinese medicine network pharmacology: theory, methodology and application.
Chin J Nat Med. 2013 Mar;11(2):110-20. doi: 10.1016/S1875-5364(13)60037-0.
7
An Integrative Platform of TCM Network Pharmacology and Its Application on a Herbal Formula, Qing-Luo-Yin.
Evid Based Complement Alternat Med. 2013;2013:456747. doi: 10.1155/2013/456747. Epub 2013 Apr 9.
8
Vitexicarpin acts as a novel angiogenesis inhibitor and its target network.
Evid Based Complement Alternat Med. 2013;2013:278405. doi: 10.1155/2013/278405. Epub 2013 Feb 12.
9
Free energy landscape for the binding process of Huperzine A to acetylcholinesterase.
Proc Natl Acad Sci U S A. 2013 Mar 12;110(11):4273-8. doi: 10.1073/pnas.1301814110. Epub 2013 Feb 25.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验